Alfonso Motolese

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Hidradenitis Suppurativa

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Li Pomi, Alfonso Motolese, Alessia Paganelli, Mario Vaccaro, Alberico Motolese, Francesco Borgia
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience. International journal of molecular sciences 25 (7) (2024)
Federica Li Pomi, Alfonso Motolese, Alessia Paganelli, Mario Vaccaro, Alberico Motolese, Francesco Borgia
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience. International journal of molecular sciences 25 (7) (2024)
Federica Li Pomi, Alfonso Motolese, Alessia Paganelli, Mario Vaccaro, Alberico Motolese, Francesco Borgia
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience. International journal of molecular sciences 25 (7) (2024)
Alessia Paganelli, Luca Contu, Alessandra Condorelli, Elena Ficarelli, Alfonso Motolese, Roberto Paganelli, Alberico Motolese
Platelet-Rich Plasma (PRP) and Adipose-Derived Stem Cell (ADSC) Therapy in the Treatment of Genital Lichen Sclerosus: A Comprehensive Review. International journal of molecular sciences 24 (22) (2023)
Laura Bonzano, Olivera Djuric, Pamela Mancuso, Lidia Fares, Raffaele Brancaccio, Marta Ottone, Eufemia Bisaccia, Massimo Vicentini, Alessia Cocconcelli, Alfonso Motolese, Rostyslav Boyko, Paolo Giorgi Rossi, Alberico Motolese
Incidence and Characteristics of Adverse Events after COVID-19 Vaccination in a Population-Based Programme. Vaccines 10 (7) (2022)
Federica Li Pomi, Laura Macca, Alfonso Motolese, Ylenia Ingrasciotta, Massimiliano Berretta, Claudio Guarneri
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments. Biomedicines 9 (11) (2021)